VTEM Banners
VTEM Banners
VTEM Banners
VTEM Banners

New Options for Purchasing Auvi-QTM EAI Devices

auvi qGood news for those looking for free epinephrine auto-injectors: Walgreens is partnering with the pharmaceutical company Kaléo to offer AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for Kaléo's patient support programs. Even those with high deductible plans might be eligible, and if you don’t have insurance, Kaléo may be able to help you through its patient assistance program. The injectors will be delivered right to your home or doctor’s office and have the added benefit of providing audio step-by-step instructions on how to administer them. Check with your doctor and apply today from the link below!

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues

  • Walgreens becomes the first retail pharmacy to offer access to AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for Kaléo’s patient support programs.
  • For patients who are unable to fill their current epinephrine prescriptions, Walgreens pharmacists will work with each patient’s healthcare practitioner to see if AUVI-Q is right for them.

Continue Reading

NY State Senator Tedisco: Police Should be Equipped with EAI Devices

Who is usually the first on the scene in any type of emergency? Law enforcement officials. It may come as a surprise to many that police officers are not allowed to administer epinephrine in an emergency, nor do they carry an EpiPen. New York State Senator Jim Tedisco is working to change this situation, since police officers now carry and administer Narcan for drug overdoses. It would be most helpful if you could email your state senator and representative to tell them of your support of Sen. Tedisco’s legislation, S.9153, to permit law enforcement officers to carry and administer EpiPens.

NY State Senator Tedisco: Police Should be Equipped with EAI Devices

By Wendy Liberatore
August 21, 2018
 
tadesco finalNew York State Senator Jim Tedisco (R-Glenville) has called for legislation to close what he calls a “dangerous loophole” by adding law enforcement, who often are first to respond to emergencies, to the list of professionals who can treat people with life-threatening allergic reactions.

Tedisco wants to enable police officers and members of law enforcement to carry epinephrine auto-injector (EAI) devices to treat people in an emergency.

Continue Reading

Opinion: Airlines Need to Get Serious About Food Allergies and In-Flight Auto-Injectors

This is a very frightening article on what could happen to someone experiencing anaphylaxis on an airplane flight. If you have a known food allergy you most likely carry your own epinephrine auto-injector device, but if it’s a first time allergic reaction you will have to hope someone on the plane has one and will lend it to you. Otherwise there would need to be a doctor or nurse on the plane who knows how to administer epinephrine with a vial and syringe, and as this article testifies, even allergists were unsure of what the dosage should be according to someone’s age. We are all for efforts to require airlines to stock EAI devices just like they do automatic electronic defibrillators (AED).

Opinion: Airlines Need to Get Serious About Food Allergies and In-Flight Auto-Injectors

NurseKellieHopkinsWithLucaIngrassia 300x243
Nurse Kellie Hopkins stepped in to give Luca an auto-injection during his in-flight emergency. Photo: Francine Ingrassia

By Lianne Mandelbaum
July 24, 2018
This article is from the Summer 2018 Allergic Living magazine.

Kellie Hopkins was buckled in for the plane ride on February 27 and about to watch a movie when she heard the public address announcement; the flight crew were asking for help from a medical professional.

Hopkins, a nurse, rushed from her seat and was soon attending to Luca, a 10-year-old from New York City, who had eaten one cashew. Though his mom, Francine Ingrassia, had never known her son to have a food allergy, Luca quickly began to experience chest pain, stomach pain and increased difficulty breathing.

Continue Reading

Latex Allergy Awareness Week Set for October 7-13

Latex Allergy Awareness Week Set for October 7-13

Perhaps you’ve seen signs in schools saying “no latex allowed” which of course would include balloons. Allergies to latex can be very serious, so the Allergy & Asthma Network is designating Oct. 7-13 as Latex Allergy Awareness Week. In addition to providing educational resources, the Network is hosting a webinar on Oct. 11, 2018 at 4 p.m. EST. Called “Latex Allergy Myths & Truths: What the Evidence Reveals,” it will feature board-certified allergist and latex allergy expert Kevin Kelly, MD, of North Carolina Children’s Hospital.


VIENNA, VA (August 31, 2018) – Allergy & Asthma Network announces Latex Allergy Awareness Week is Sunday, Oct. 7 to Saturday, Oct. 13, 2018. The theme this year is “Latex Allergy Myths & Truths: What the Evidence Reveals.”

AllergyAsthmaNetwork Logo 285x168During Latex Allergy Awareness Week, the Network raises awareness about the condition, which affects 1 to 6 percent of the population, and distributes educational resources in print and online. The week is intended to highlight the many issues facing people with latex allergy as well as encourage doctors and patients to stay vigilant in efforts to fully understand the condition and eliminate exposure to latex everywhere.

Continue Reading

FDA Approves First Generic Epi-Pen(TM) in Blow to Mylan

At long last, a potentially less expensive epinephrine auto-injector (EAI) device may be available to consumers very soon. TEVA Pharmaceuticals has received US government approval for a generic version of the Epi-PenTM originally made and marketed by Mylan Pharmaceuticals. Additional generic devices are on their way as well. The existing market for EAI devices is very large; different brands competing against each other could lead to lower prices. Our association fully supports any and all efforts aimed at better regulating healthcare costs for all Americans.

FDA Approves First Generic Epi-PenTM in Blow to Mylan

VibexTMAutoInjector 361x189 
TEVA Antares VibexTM epinephrine auto-injector device

FDA Approves TEVA Generic Version of the Epi-PenTM

By Nathan Bomey
USA TODAY
Aug. 16, 2018

The EpiPen is getting a fresh dose of competition.

The Food and Drug Administration on Thursday approved what it described as the first official generic version of the EpiPen, a life-saving treatment for severe allergic reactions.

The generic device's seller, Teva Pharmaceuticals, is a rival to drug maker Mylan's brand-name version.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2018 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions